Clinical study to analyze the modification of autoinflammatory disease-related gene abnormalities on the pathology of systemic lupus erythematosus

Clinical study to analyze the modification of autoinflammatory disease-related gene abnormalities on the pathology of systemic lupus erythematosus - The modification of autoinflammatory disease-related gene abnormalities on the pathology of systemic lupus erythematosus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034052

Enrollment

160

Registered

2018-09-10

Start date

2018-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus (SLE)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: SLE patients who satisfy the classification criteria.

Exclusion criteria

Exclusion criteria: Patients judged inappropriate as subjects of research.

Design outcomes

Primary

Measure	Time frame
Elucidation of differences between clinical findings of SLE with and without autoinflammatory disease-related gene abnormality	—

Countries

Japan

Contacts

Public ContactYushiro Endo

Nagasaki University Graduate School of Biomedical Sciences Department of Immunology and Rheumatology

yushiro19861105@hotmail.co.jp095-819-7200

Outcome results